Atazanavir: all 109 studies that test it

Page 1 of 2. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV TreatmentsRecruitingNCT06337032Phase 4
• Atazanavir and Endothelial Function in Older HIV PatientsCompletedNCT03019783Phase 2/3Results posted
• Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected AdultsCompletedNCT02603107Phase 3Results posted
• Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected AdultsCompletedNCT02246998Phase 4Results posted
• Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced AdultsCompletedNCT01967940Phase 3Results posted
• Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With CobicistatCompletedNCT01837719Phase 1Results posted
• Study to Evaluate a HIV Drug for the Treatment of HIV InfectionCompletedNCT01803074Phase 2Results posted
• Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive WomenCompletedNCT01705574Phase 3Results posted
• Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric PatientsCompletedNCT01691794Phase 4Results posted
• A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes MellitusCompletedNCT01421355Phase 1Results posted
• Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy SubjectsCompletedNCT01404572Phase 1Results posted
• Genetics and HIV-1 Protease InhibitorsCompletedNCT01388543Phase 4Results posted
• Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal ImpairmentCompletedNCT01363011Phase 3Results posted
• Switch to Unboosted Atazanavir With Tenofovir StudyCompletedNCT01351740Phase 4Results posted
• Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV InfectionCompletedNCT01232127Phase 4Results posted
• A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)CompletedNCT01102972Phase 4Results posted
• PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)CompletedNCT01099579Phase 3Results posted
• Roll-Over Protocol To Provide Atv And/Or Truvada For Extended AccessCompletedNCT01003990Phase 3Results posted
• Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART RegimensCompletedNCT00940771Phase 4Results posted
• BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.CompletedNCT00931801Phase 4Results posted
• TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV PatientsCompletedNCT00896051Phase 2Results posted
• Atazanavir and Lamivudine for Treatment SimplificationCompletedNCT00885482Phase 4Results posted
• Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy WomenCompletedNCT00869960Phase 4Results posted
• Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy ParticipantsCompletedNCT00833482Phase 1Results posted
• Comparative Study of Three NNRTI-Sparing HAART RegimensCompletedNCT00811954Phase 3Results posted
• Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected PatientsCompletedNCT00762892Phase 4Results posted
• Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received TreatmentCompletedNCT00757783Phase 4Results posted
• Drug Interaction StudyCompletedNCT00646776Phase 1Results posted
• Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)CompletedNCT00552240Phase 4Results posted
• Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 InfectionCompletedNCT00440947Phase 3Results posted
• Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic SuppressionCompletedNCT00337467Phase 3Results posted
• ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial RegimensCompletedNCT00335322Phase 4Results posted
• Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant WomenCompletedNCT00326716Phase 1Results posted
• BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose TruvadaCompletedNCT00272779Phase 3Results posted
• Switch to Atazanavir and Brachial Artery Reactivity (SABAR) StudyCompletedNCT00225017Phase 3Results posted
• Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)CompletedNCT00207142Phase 4Results posted
• Study of Reyataz in HIV-infected Patients With Lipodystrophy SyndromeCompletedNCT00135356Phase 4Results posted
• Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive AdultsCompletedNCT00118898Phase 3Results posted
• Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited SettingsCompletedNCT00084136Phase 4Results posted
• Preventing Sexual Transmission of HIV With Anti-HIV DrugsCompletedNCT00074581Phase 3Results posted
• Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIVCompletedNCT00035932Phase 3Results posted
• A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed ConditionsCompletedNCT05236738Phase 1
• Antiviral Agents Against COVID-19 InfectionCompletedNCT04468087Phase 2/3
• The Nitazoxanide Plus Atazanavir for COVID-19 StudyTerminatedNCT04459286Phase 2
• Pharmacokinetics of Maraviroc and Boosted Atazanavir Dual Regimen in Stable HIV-infected PatientsWithdrawnNCT03708861Phase 3
• Pharmacokinetics of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance RegimenTerminatedNCT02566707Phase 2
• A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/CobicistatCompletedNCT02565888Phase 1
• A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable ViremiaCompletedNCT02542852Phase 2
• Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected PatientsCompletedNCT02473328Phase 2
• Taste Properties of Atazanavir and CobicistatCompletedNCT02307656Phase 1
• Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of RitonavirCompletedNCT02253836Phase 1
• ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to AtazanavirStatus unknownNCT02102048Not applicable
• Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic StudyCompletedNCT02034838Phase 1
• Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIVActive, not recruitingNCT02016924Phase 2/3
• Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 CountsCompletedNCT01928407Phase 4
• Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to RaltegravirTerminatedNCT01902186Phase 4
• Pharmacokinetic Interactions Between Telaprevir and Un-boosted AtazanavirCompletedNCT01818856Phase 1
• Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI BackboneWithdrawnNCT01605084Phase 3
• Atazanavir/r + Lamivudine Dual TherapyCompletedNCT01599364Phase 4
• A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or AtazanavirCompletedNCT01592305Phase 1
• A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy VolunteersCompletedNCT01591850Phase 1
• Pharmacokinetics, Safety & Tolerability of Isotopologs of Atazanavir (ATV), With Pharmacokinetic Comparison to ReyatazCompletedNCT01458769Phase 1
• Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male VolunteersStatus unknownNCT01368783Phase 1
• Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected PatientsCompletedNCT01274780Phase 4
• A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/RitonavirWithdrawnNCT01255371Phase 3
• Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected PatientsCompletedNCT00943540Phase 2
• The Effects of Atazanavir-induced Hyperbilirubinemia During Human EndotoxemiaCompletedNCT00916448Not applicable
• GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and AtazanavirCompletedNCT00883935Phase 1
• Disulfiram Interactions With HIV Medications: Clinical ImplicationsCompletedNCT00878306Phase 1
• Raltegravir and Atazanavir Dosing Strategy StudyCompletedNCT00874523Phase 3
• Early and Intermittent Antiretroviral Therapy in Naive HIV Infected AdultsCompletedNCT00820118Phase 2
• Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current TreatmentStatus unknownNCT00751153Phase 4
• Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk FactorsCompletedNCT00720590Not applicable
• Comparison of Epzicom and Truvada for the Initial Once Daily HIV TreatmentCompletedNCT00544128Phase 4
• Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and TruvadaCompletedNCT00528060Phase 2
• HIV Antiretroviral Drugs and MetabolismStatus unknownNCT00525239Not applicable
• DDI HV (ATV - Merck)CompletedNCT00518297Phase 1
• Effect of Atazanavir on Endothelial Function in HIV-Infected PatientsCompletedNCT00447070Phase 4
• SHARE: Simple HAART With Abacavir, Reyataz, and EpivirStatus unknownNCT00426296Phase 4
• Pharmacokinetic Study of Two HIV Protease Inhibitors in PatientsTerminatedNCT00420355Phase 4
• Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected PatientsCompletedNCT00411957Phase 1/2
• Bioequivalence Study of Atazanavir 300 mg CapsuleCompletedNCT00393328Phase 1
• Atazanavir or Lopinavir in HIV Post-exposure ProphylaxisCompletedNCT00385645Phase 4
• Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected PatientsCompletedNCT00384904Phase 4
• Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/TenofovirCompletedNCT00365339Phase 1
• Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate RosiglitazoneCompletedNCT00362726Phase 1
• Atazanavir Twice DailyCompletedNCT00357721Phase 1
• Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy FemalesCompletedNCT00357604Phase 1
• Drug Interaction Study With Proton Pump InhibitorCompletedNCT00357240Phase 1
• Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy SubjectsCompletedNCT00357188Phase 1
• Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV PatientsCompletedNCT00355719Phase 4
• A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic SyndromeTerminatedNCT00312754Phase 4
• Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedNCT00307502Phase 1
• Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV TreatmentCompletedNCT00280969Phase 3
• Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected ChildrenCompletedNCT00260078Phase 1/2
• Boosted Atazanavir and Truvada Given Once-Daily - BATON StudyCompletedNCT00224445Phase 4
• ATV/Ritonavir Nevirapine Interaction (USPAC)CompletedNCT00162149Phase 1
• Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With HyperlipidemiaCompletedNCT00160329Phase 3
• Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin MetabolismCompletedNCT00135434Phase 1
• A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART RegimenCompletedNCT00135395Phase 3

← Atazanavir overview